Literature DB >> 34073560

Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles.

Irène Tatischeff1.   

Abstract

There exist many different human cancers, but regardless of the cancer type, an early diagnosis is a necessary condition for further optimal outcomes from the disease. Therefore, efficient specific and sensitive cancer biomarkers are urgently needed. This is especially true for the cancers depicting a silent progression, and those only diagnosed in an already metastatic state with a poor survival prognostic. After a rapid overview of the previous methods for cancer diagnosis, the outstanding characteristics of extracellular vesicles (EVs) will be presented, as new interesting candidates for early cancer diagnosis in human biofluid non-invasive liquid biopsy. The present review aims to give the state-of-the-art of the numerous searches of efficient EV-mediated cancer diagnosis. The corresponding literature quest was performed by means of an original approach, using a powerful Expernova Questel big data platform, which was specifically adapted for a literature search on EVs. The chosen collected scientific papers are presented in two parts, the first one drawing up a picture of the current general status of EV-mediated cancer diagnosis and the second one showing recent applications of such EV-mediated diagnosis for six important human-specific cancers, i.e., lung, breast, prostate, colorectal, ovary and pancreatic cancers. However, the promising perspective of finally succeeding in the worldwide quest for the much-needed early cancer diagnosis has to be moderated by the many remaining challenges left to solve before achieving the efficient clinical translation of the constantly increasing scientific knowledge.

Entities:  

Keywords:  apoptotic bodies); breast; colorectal; extracellular vesicles (exosomes; microvesicles; oncosomes; ovary; pancreatic); prostate; specific human cancers (lung

Year:  2021        PMID: 34073560     DOI: 10.3390/ijms22115674

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  81 in total

1.  Dual-SERS biosensor for one-step detection of microRNAs in exosome and residual plasma of blood samples for diagnosing pancreatic cancer.

Authors:  Yuanfeng Pang; Chaoguang Wang; LuChun Lu; Chongwen Wang; Zhiwei Sun; Rui Xiao
Journal:  Biosens Bioelectron       Date:  2019-01-25       Impact factor: 10.618

2.  How can plasma RNA be used to diagnose prostate cancer?

Authors:  Xiaolei Shi; Shancheng Ren; Yinghao Sun
Journal:  Expert Rev Anticancer Ther       Date:  2016-12-10       Impact factor: 4.512

3.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

4.  Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification.

Authors:  Shimeng Fang; Hongzhu Tian; Xiancheng Li; Dong Jin; Xiaojie Li; Jing Kong; Chun Yang; Xuesong Yang; Yao Lu; Yong Luo; Bingcheng Lin; Weidong Niu; Tingjiao Liu
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

5.  Diagnostic value of various liquid biopsy methods for pancreatic cancer: A systematic review and meta-analysis.

Authors:  Yuzhou Zhu; Hao Zhang; Nan Chen; Jianqi Hao; Hongyu Jin; Xuelei Ma
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

6.  Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.

Authors:  Limin Niu; Xingguo Song; Ning Wang; Linlin Xue; Xianrang Song; Li Xie
Journal:  Cancer Sci       Date:  2018-12-06       Impact factor: 6.716

Review 7.  Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.

Authors:  Lei Chang; Jie Ni; Ying Zhu; Bairen Pang; Peter Graham; Hao Zhang; Yong Li
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

8.  Determination of Serum Exosomal H19 as a Noninvasive Biomarker for Breast Cancer Diagnosis.

Authors:  Guobin Zhong; Keqiong Wang; Jiawei Li; Shuzhe Xiao; Wei Wei; Jianlun Liu
Journal:  Onco Targets Ther       Date:  2020-03-27       Impact factor: 4.147

9.  A five-miRNA panel in plasma was identified for breast cancer diagnosis.

Authors:  Minghui Li; Xuan Zou; Tiansong Xia; Tongshan Wang; Ping Liu; Xin Zhou; Shui Wang; Wei Zhu
Journal:  Cancer Med       Date:  2019-09-30       Impact factor: 4.452

10.  Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis.

Authors:  Li Sun; Xiangxiang Liu; Bei Pan; Xiuxiu Hu; Yefei Zhu; Yingying Su; Zhirui Guo; Guoying Zhang; Mu Xu; Xueni Xu; Huiling Sun; Shukui Wang
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

View more
  6 in total

Review 1.  Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine.

Authors:  Yasunari Matsuzaka; Ryu Yashiro
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

Review 2.  Multi-Omics Integrative Approach of Extracellular Vesicles: A Future Challenging Milestone.

Authors:  Enxhi Shaba; Lorenza Vantaggiato; Laura Governini; Alesandro Haxhiu; Guido Sebastiani; Daniela Fignani; Giuseppina Emanuela Grieco; Laura Bergantini; Luca Bini; Claudia Landi
Journal:  Proteomes       Date:  2022-04-22

3.  A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma.

Authors:  Carmen Campos-Silva; Yaiza Cáceres-Martell; Estela Sánchez-Herrero; Amaia Sandúa; Alexandra Beneitez-Martínez; Álvaro González; Mariano Provencio; Atocha Romero; Ricardo Jara-Acevedo; María Yáñez-Mó; Mar Valés-Gómez
Journal:  J Nanobiotechnology       Date:  2022-02-08       Impact factor: 10.435

4.  Vesicular MicroRNA as Potential Biomarkers of Viral Rebound.

Authors:  Wilfried Wenceslas Bazié; Julien Boucher; Isidore Tiandiogo Traoré; Dramane Kania; Diane Yirgnur Somé; Michel Alary; Caroline Gilbert
Journal:  Cells       Date:  2022-03-02       Impact factor: 6.600

Review 5.  The integrated comprehension of lncRNA HOXA-AS3 implication on human diseases.

Authors:  Qinfan Yao; Cuili Wang; Yucheng Wang; Xiuyuan Zhang; Hong Jiang; Dajin Chen
Journal:  Clin Transl Oncol       Date:  2022-08-20       Impact factor: 3.340

Review 6.  Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer.

Authors:  Simita Gaglani; Edgar Gonzalez-Kozlova; Dara J Lundon; Ashutosh K Tewari; Navneet Dogra; Natasha Kyprianou
Journal:  Int J Mol Sci       Date:  2021-09-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.